Skip to content
ScienceDirrect

Journal of Taibah University Medical Sciences

Date: 19 October 2026

Volume 21, Issue 5 · Pages: 1260–1273

Show more⌄
Original Article● Open accessUnder a Creative Commons license ↗
Original Article

Chitosan and nanochitosan haemostatic agents attenuate haemorrhagic coagulopathy and fibrinolysis: a rabbit study

Show more⌄

Abstract

Background Uncontrolled haemorrhage is the leading cause of potentially survivable death in combat casualties. Aim To compare the effects of a chitosan-based and a nanochitosan-based haemostatic agent with a reference agent on coagulation, fibrinolysis, platelets and angiogenic growth factors in an experimental haemorrhage model. Methods Thirty adult rabbits (2.1–2.3 kg) were randomly allocated to five…

Keywords
Blood Coagulation; Chitosan; Hemorrhage; Hemostatics; Nanoparticles; Wounds and Injuries

Authors and affiliations

Alisher T. Tukhtapulatov, Z.A. Pulatova, R.Y. Milusheva, V.N. Raxmanova, D.B. Axmedova, F.X. Mirdjalilov, Z.R. Xasanov

Author affiliations are listed in the full article PDF.

Background

Uncontrolled haemorrhage is the leading cause of potentially survivable death in combat casualties.

Aim

To compare the effects of a chitosan-based and a nanochitosan-based haemostatic agent with a reference agent on coagulation, fibrinolysis, platelets and angiogenic growth factors in an experimental haemorrhage model.

Methods

Thirty adult rabbits (2.1–2.3 kg) were randomly allocated to five groups (n = 6): intact, untreated haemorrhage (control), reference agent, chitosan and nanochitosan. Blood loss, bleeding time, prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), international normalised ratio (INR), fibrinogen, D-dimer, platelet count, vascular endothelial growth factor (VEGF) and transforming growth factor-β (TGF-β) were measured 1, 3, 12, 24 and 72 h after injury.

Results

In untreated animals, blood loss was 8.27–8.50 mL and bleeding time 19.8–23.6 min. Haemorrhage prolonged PT (12.83 to 16.55 s) and APTT (36.83 to 64.5 s), increased D-dimer more than fivefold (0.25 to 1.33 µg/mL) and reduced platelets (333.3 to 237.2 × 103/µL) by 72 h. All agents attenuated these changes, most markedly nanochitosan: PT was 9.4% and 11.0% shorter than in controls at 1 and 72 h, APTT 12.2% and 12.7% shorter, D-dimer 2.2-fold lower (0.47 and 0.60 vs. 1.03 and 1.33 µg/mL) and platelets higher (278.5 and 280.0 vs. 249.0 and 237.2 × 103/µL). Haemorrhage increased VEGF (97.5 to 189.7 ng/mL) and TGF-β (72.7 to 267.5 pg/mL); the rise was smallest with nanochitosan (152.8 ng/mL and 238.5 pg/mL at 72 h).

Conclusion

In this rabbit model, nanochitosan attenuated haemorrhage-associated coagulopathy, hyperfibrinolysis and thrombocytopenia more effectively than conventional chitosan or the reference agent. Confirmation of local haemostatic efficacy and thrombotic safety in standardised large-animal models is required before clinical use.

Full article

Open the full article PDF

How to cite

Alisher T. Tukhtapulatov, Z.A. Pulatova, R.Y. Milusheva, V.N. Raxmanova, D.B. Axmedova, F.X. Mirdjalilov, Z.R. Xasanov. (2026). Chitosan and nanochitosan haemostatic agents attenuate haemorrhagic coagulopathy and fibrinolysis: a rabbit study. Journal of Taibah University Medical Sciences, Volume 21, Issue 5, 1260–1273. Article ID: SDR-2026-0033.

All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
RELX